The batch included, among the CLN6 and the control group, a group made of eight types of neuronal ceroid lipofuscinoses diseases (CLN2, CLN3, CLN5, CLN7, CLN8, CLN12, and CLN14), and one that comprised ten types of LSDs (Mucopolysaccharidosis type I, Mucopolysaccharidosis type II, Mucopolysaccharidosis type IIIa, Mucopolysaccharidosis type IV, Spinal muscular atrophy, Fabry disease, Gaucher disease, Krabbe disease, Metachromatic leukodystrophy, and GM1 gangliosidosis disease). This evidence concerns the gene TPP1 and spinal muscular atrophy.